16:09 EDT Aprea Therapeutics files to sell 4.39M shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APRE:
- Aprea Therapeutics price target raised to $11 from $9 at Wedbush
- Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
- Aprea Therapeutics sees cash runway into 3Q25
- Aprea Therapeutics reports Q4 EPS (92c), consensus (77c)
- APRE Upcoming Earnings Report: What to Expect?